Global genomics in over 4 million individuals prioritizes therapeutic targets for heart failure and its subtypes
This study leverages multi-ancestry genomic data from over 4 million individuals to identify hundreds of novel genetic loci and druggable targets for heart failure and its subtypes, highlighting the critical role of metabolic pathways and supporting the expansion of existing therapies like aldosterone synthase inhibitors and type-II activin receptor antagonists.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Imagine your body as a bustling city where the heart is the central power plant, pumping energy to every neighborhood. Sometimes, this power plant gets tired and can't keep up with the city's demands, a condition doctors call heart failure. For years, scientists have tried to fix this by looking at the city's blueprints—the DNA inside our cells—to find out why the plant fails. Think of DNA like a massive instruction manual written in a code of four letters. If there's a typo in the manual, the instructions might get garbled, leading to a broken machine. In the past, most scientists only read the manuals from people of European descent, like trying to understand a whole library by only reading books from one specific shelf. This paper, however, decided to read millions of manuals from people of all different backgrounds, looking for typos that might explain why the heart gives up. By using a clever statistical trick called Mendelian randomization—which treats our genes like a natural lottery to see if a specific instruction actually causes a problem rather than just being related to it—the researchers hope to find the exact switches in the body's machinery that, if flipped, could stop heart failure before it starts or help fix it when it's already broken.
This massive study, involving over 4.4 million people, is like a giant detective squad scouring the genetic instruction manuals of the world to find the hidden clues behind heart failure. The researchers didn't just look at heart failure as one big problem; they split it into two main types: one where the heart muscle gets weak and shrinks (called HFrEF), and another where the muscle gets stiff and can't fill up properly (called HFpEF). By comparing the DNA of over 345,000 people with heart failure against millions of healthy people, they found 383 specific spots in the genetic code where the instructions were different. Of these, 166 spots were brand new discoveries that no one had ever seen before.
The team then acted like genetic detectives, tracing these spots to find the specific genes responsible. They identified 568 genes in total, with 375 of them being new suspects. But finding the gene is only half the battle; the real magic happened when they asked, "Can we fix this?" They discovered that 11 of these new genes are actually targets for drugs that already exist or are currently being tested. For example, they found that a gene called CYP11B2, which is currently targeted by drugs for high blood pressure, might also be a key player in heart failure. Similarly, a gene called ACVR2A, targeted by drugs for lung issues, could be repurposed to help hearts that are too stiff. This suggests that doctors might be able to use these existing medicines for heart failure patients sooner than expected, essentially giving old tools a new job.
The study also uncovered a fascinating connection between the heart and the body's energy system. They found nearly 100 genes related to how the body eats, burns fat, and produces energy. It turns out the heart is a picky eater that needs a steady supply of fuel, and when the body's metabolism (the way it processes food and fat) gets out of whack, the heart suffers. The researchers found that genes involved in breaking down fats and sugars, as well as genes that control how much we eat, are deeply linked to heart failure. This is a big deal because it suggests that managing heart failure isn't just about the heart itself, but also about the body's entire energy factory.
Furthermore, the researchers looked at how these genetic clues relate to the heart's structure. They found that some of the new genes are like the screws and bolts that hold the heart muscle together. When these "screws" are defective, the heart muscle can't contract properly or gets damaged. They also found that genes involved in inflammation and how fat cells talk to other parts of the body (acting like messengers) play a huge role, especially in the stiff type of heart failure.
In short, this paper doesn't just give us a list of genetic typos; it gives us a map. It points to specific parts of the body's machinery—like the energy production line, the fat-burning system, and the structural bolts of the heart—that are broken in heart failure. Most importantly, it suggests that we might already have the wrenches to fix some of these broken parts. While the study is a massive step forward, the authors are careful to say that these findings are strong suggestions based on genetic data, and they will need to be tested in real-world clinical trials to see if they truly work as treatments. But for the first time, we have a clear, multi-ancestry view of the genetic landscape of heart failure, offering hope that new, effective treatments are just around the corner.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.